GSAC GelStat Corporation (PK)

GelStat Corporation (Other OTC:GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain, inflammation and sleep disorders, is pleased to announce that Mr. Paul W. Bucha has joined its Board of Directors.

Mr. Bucha has over 40 years of experience, serving a number of senior executive level leadership positions within a wide range of industries including real estate, international trade, international licensing, manufacturing, marketing hospitality and defense contracting. Prior to his foray into the business world, Mr. Bucha served as a Captain and Company Commander in the elite U.S. Army Rangers, and is one of the 85 living recipients of the Congressional Medal of Honor. While serving, Mr. Bucha also earned the Bronze Star, a Purple Heart, Vietnam Cross of Gallantry, the Army Commendation Medal, the Civic Action Medal, the National Defense Service Medal, and the Vietnam Service Medal. Mr. Bucha earned his Masters of Business Administration at Stanford University Graduate School of Business and earned his undergraduate education at the United States Military Academy at West Point.

Gerald Kieft, CEO of GelStat stated, "We are honored that Mr. Bucha has chosen to join our Board of Directors and we look forward to his guidance. We believe that his background and skills will be invaluable to us as we move forward and continue to execute our business plan." 

Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStatr's email news alert system today at: http://ir.stockpr.com/gelstat/request-information

ABOUT GELSTAT CORPORATION

GelStat Corporation is dedicated to providing safe and effective over-the-counter (OTC) treatments for pain, inflammation and sleep disorders. GelStat's first two products GelStat Migraine and GelStat Sleep are sold through direct-to-consumer channels as well as in a limited number of independent retailers and pharmacies. The Company also has a suite of additional healthcare products in various stages of development that address large consumer markets. For more information, visit www.gelstat.com.

CONTACT: Gerald Kieft
         CEO
         GelStat Corporation
         772-283-0020